United States Biopsy Procedures Outlook to 2023
June 2017
43
About the Report
About the Report
United States Biopsy Procedures Outlook to 2023
Summary
GlobalData's new report, "United States Biopsy Procedures Outlook to 2023", provides key procedures data on the United States Biopsy Procedures. The report provides procedure volumes within market segments-Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.
Scope
United States Biopsy Procedures volumes by segments-Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
Reasons to buy
Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
Develop market-entry and market expansion strategies.
Products
Products
General Surgery, Procedurs Bariatric Procedures, Biopsy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatic and Biliary Stenting Procedures, Gastric Balloon Procedures, Enteral Stenting Procedures, Hernia Repair Procedures, Female Sterilization Procedures, Percutaneous Transhepatic Cholangiography (PTC) Pancreatic and Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Transcervical Resection of the Endometrium (TCRE) Procedures, Urinary Tract Stenting Procedures, Uterine Fibroid Embolization (UFE) Procedures Procedure Volume, Historic Procedure Numbers, Forecast Procedure Numbers
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Biopsy Procedures, Segmentation 4
2.3 Definitions of Procedures Covered in the Report 5
3 Biopsy Procedures, United States 7
3.1 Biopsy Procedures, United States, 2009-2016 7
3.2 Biopsy Procedures, United States, 2016-2023 9
3.2.1 Breast Biopsy Procedures, United States, 2009-2016 11
3.2.2 Colorectal Biopsy Procedures, United States, 2009-2016 13
3.2.3 Leukemia Biopsy Procedures, United States, 2009-2016 15
3.2.4 Liver Biopsy Procedures, United States, 2009-2016 16
3.2.5 Lung Biopsy Procedures, United States, 2009-2016 18
3.2.6 Other Indications Biopsy Procedures, United States, 2009-2016 19
3.2.7 Prostate Biopsy Procedures, United States, 2009-2016 21
3.2.8 Thyroid Biopsy Procedures, United States, 2009-2016 23
3.2.9 Breast Biopsy Procedures, United States, 2016-2023 24
3.2.10 Colorectal Biopsy Procedures, United States, 2016-2023 26
3.2.11 Leukemia Biopsy Procedures, United States, 2016-2023 28
3.2.12 Liver Biopsy Procedures, United States, 2016-2023 29
3.2.13 Lung Biopsy Procedures, United States, 2016-2023 31
3.2.14 Other Indications Biopsy Procedures, United States, 2016-2023 32
3.2.15 Prostate Biopsy Procedures, United States, 2016-2023 34
3.2.16 Thyroid Biopsy Procedures, United States, 2016-2023 36
4 Appendix 37
4.1 Research Methodology 38
4.1.1 Coverage 38
4.1.2 Secondary Research 38
4.1.3 Primary Research 39
4.1.4 Market Modeling and Forecasting 40
4.1.5 Company Share Analysis 41
4.1.6 Distribution Share Analysis 42
4.1.7 Benchmarking 42
4.2 GlobalData Consulting 42
4.3 Contact Us 43
4.4 Disclaimer 43
List of Figure
1.2 List of Figures
Figure 1: Biopsy Procedures, United States, Historic, 2009-2016 7
Figure 2: Biopsy Procedures, United States, Forecast, 2016-2023 9
Figure 3: Breast Biopsy Procedures, United States, Historic, 2009-2016 11
Figure 4: Colorectal Biopsy Procedures, United States, Historic, 2009-2016 13
Figure 5: Leukemia Biopsy Procedures, United States, Historic, 2009-2016 15
Figure 6: Liver Biopsy Procedures, United States, Historic, 2009-2016 16
Figure 7: Lung Biopsy Procedures, United States, Historic, 2009-2016 18
Figure 8: Other Indications Biopsy Procedures, United States, Historic, 2009-2016 19
Figure 9: Prostate Biopsy Procedures, United States, Historic, 2009-2016 21
Figure 10: Thyroid Biopsy Procedures, United States, Historic, 2009-2016 23
Figure 11: Breast Biopsy Procedures, United States, Forecast, 2016-2023 24
Figure 12: Colorectal Biopsy Procedures, United States, Forecast, 2016-2023 26
Figure 13: Leukemia Biopsy Procedures, United States, Forecast, 2016-2023 28
Figure 14: Liver Biopsy Procedures, United States, Forecast, 2016-2023 29
Figure 15: Lung Biopsy Procedures, United States, Forecast, 2016-2023 31
Figure 16: Other Indications Biopsy Procedures, United States, Forecast, 2016-2023 32
Figure 17: Prostate Biopsy Procedures, United States, Forecast, 2016-2023 34
Figure 18: Thyroid Biopsy Procedures, United States, Forecast, 2016-2023 36
List of Table
1.1 List of Tables
Table 1: Biopsy Procedures, United States, Historic, 2009-2016 8
Table 2: Biopsy Procedures, United States, Forecast, 2016-2023 10
Table 3: Breast Biopsy Procedures, United States, Historic, 2009-2016 12
Table 4: Colorectal Biopsy Procedures, United States, Historic, 2009-2016 14
Table 5: Leukemia Biopsy Procedures, United States, Historic, 2009-2016 15
Table 6: Liver Biopsy Procedures, United States, Historic, 2009-2016 17
Table 7: Lung Biopsy Procedures, United States, Historic, 2009-2016 18
Table 8: Other Indications Biopsy Procedures, United States, Historic, 2009-2016 20
Table 9: Prostate Biopsy Procedures, United States, Historic, 2009-2016 22
Table 10: Thyroid Biopsy Procedures, United States, Historic, 2009-2016 23
Table 11: Breast Biopsy Procedures, United States, Forecast, 2016-2023 25
Table 12: Colorectal Biopsy Procedures, United States, Forecast, 2016-2023 27
Table 13: Leukemia Biopsy Procedures, United States, Forecast, 2016-2023 28
Table 14: Liver Biopsy Procedures, United States, Forecast, 2016-2023 30
Table 15: Lung Biopsy Procedures, United States, Forecast, 2016-2023 31
Table 16: Other Indications Biopsy Procedures, United States, Forecast, 2016-2023 33
Table 17: Prostate Biopsy Procedures, United States, Forecast, 2016-2023 35
Table 18: Thyroid Biopsy Procedures, United States, Forecast, 2016-2023 36
Table 19: Total Number of Primary Research Participants, General Surgery Market, by Country 40
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.